STOCK TITAN

ParkerVision Reports 2022 Results

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Negative)
Tags
Rhea-AI Summary

ParkerVision, Inc. (OTCQB:PRKR) reported its 2022 financial results, showcasing a net loss of $9.8 million, improved from a loss of $12.3 million in 2021. The company secured $25 million in settlement agreements related to patent infringements, with additional patents targeting MediaTek and Realtek. The appeal involving Qualcomm is anticipated for mid-2023. Cash used for operations decreased to $3 million compared to $7.7 million in 2021, partly due to reduced accounts payable. The firm expects significant revenues from ongoing patent enforcement, aiming for profitability in 2023.

Positive
  • Received $25 million from patent settlements.
  • 20% reduction in net loss compared to 2021, totaling $9.8 million.
  • Secured $0.8 million in net proceeds from securities sales in January 2023.
  • Reduced cash used for operations by $4.7 million year-over-year.
Negative
  • Total assets decreased from $3.44 million in 2021 to $1.75 million in 2022.
  • Cash and cash equivalents dropped significantly from $1.03 million at the beginning of the year to $109,000 by year-end.
  • Total liabilities increased, leading to a shareholder deficit of $(50.7 million).

JACKSONVILLE, FL / ACCESSWIRE / March 28, 2023 / ParkerVision, Inc. (OTCQB:PRKR) ("ParkerVision"), a developer and marketer of technologies and products for wireless applications, today announced results for the year ended December 31, 2022.

Year End 2022 Summary and Recent Developments

Through March 2023, the Company has resolved patent infringement actions filed in 2020 and 2021 in the Western District of Texas against four of six defendants through patent license and settlement agreements, including one agreement reached in the first quarter of 2023 for which the Company received $25 million in gross proceeds.

New patent infringement cases were filed against MediaTek and Realtek in the Western District of Texas in the fourth quarter of 2022.

  • Pending cases against TCL and LG in Texas are stayed pending outcome of one or both of the Realtek and MediaTek actions.

Hearing at the Federal Circuit for the Company's appeal in ParkerVision v. Qualcomm is expected to be held mid-2023.

  • The appeal is the result of March 2022 Florida district court rulings in Qualcomm's favor on pre-trial motions that resulted in eliminating all matters for a jury to decide in an infringement case against Qualcomm that was nearing trial after being filed nearly nine years prior in 2014.
Sanford (Sandy) Litvack joined the ParkerVision board of directors in October 2022.

Jeffrey Parker, Chairman and Chief Executive Officer, commented, "ParkerVision holds a portfolio of over 100 patents on our inventions, including a number of expired patents for which claims can be made for past damages, as well as a number of patents that will not expire for years to come. We believe our technologies are being used, without our permission, in a range of cellular, Wifi and Bluetooth chips and devices. Our patented technologies have all been developed in-house as a result of significant R&D investments, and our team includes our lead inventors whose knowledge and experience provide a strong foundation for enforcing the property rights of our claims against companies who we believe are wrongly using our patented inventions."

Mr. Parker continued, "We currently have patent enforcement cases pending against Qualcomm, Apple, TCL, LG, MediaTek and Realtek, and expect to file additional cases this year. We also have a patent enforcement action against Qualcomm, involving significant damages claims, on which we have filed an appeal at the Federal Circuit. We anticipate a hearing date for our appeal will be set for mid-2023.

"The incoming revenues from our overall patent enforcement program, after payment of contingent legal fees and expenses, will be used to reduce a significant portion of the Company's contingent debt. We expect 2023 to be a profitable year for ParkerVision."

Financial Results

Net loss for 2022 was $9.8 million, or $0.13 per common share, compared to a net loss of $12.3 million, or $0.17 per common share for 2021.
oThe 20% decrease in year-to-date net loss is a primarily the result of
a $0.8 million increase in revenue resulting from our patent enforcement and litigation efforts.
a $1.6 million decrease in the loss related to the change in fair value of our contingent payment obligations.
We used cash for operations of approximately $3.0 million in 2022 compared to approximately $7.7 million in cash used for operations in 2021. The decrease is primarily the result of the use of approximately $3.9 million in cash for the reduction of accounts payable and accrued expenses during the year ended December 31, 2021, as compared to a $0.4 million increase in accounts payable and accrued expenses during the year ended December 31, 2022.
oIn 2022, we received net proceeds of approximately $2.1 million from the sale of debt and equity securities.
oWe received approximately $0.8 million in net proceeds from the sale of debt and equity securities in January 2023.

About ParkerVision

ParkerVision, Inc. invents, develops and licenses cutting-edge, proprietary radio-frequency (RF) technologies that enable wireless solution providers to make and sell advanced wireless communication products. ParkerVision is engaged in a number of patent enforcement actions in the U.S. to protect patented rights that it believes are broadly infringed by others. For more information, please visit www.parkervision.com. (PRKR-I)

Safe Harbor Statement

This press release contains forward-looking information. Readers are cautioned not to place undue reliance on any such forward-looking statements, each of which speaks only as of the date made. Such statements are subject to certain risks and uncertainties that are disclosed in the Company's SEC reports, including the Form 10-K for the year ended December 31, 2022. These risks and uncertainties could cause actual results to differ materially from those currently anticipated or projected.



Cindy French

Chief Financial Officer

ParkerVision, Inc

cfrench@parkervision.com



(TABLES FOLLOW)

ParkerVision, Inc.
Balance Sheet Highlights


December 31,
(in thousands)
2022 2021
Cash and cash equivalents
$109 $1,030
Prepaid expenses and other current assets
274 599
Intangible assets, net
1,359 1,785
Other noncurrent assets, net
9 26
Total assets
1,751 3,440

Current liabilities
2,257 1,646
Contingent payment obligations
45,797 43,063
Convertible notes
3,913 2,895
Other long-term liabilities
473 613
Shareholders' deficit
(50,689) (44,777)
Total liabilities and shareholders' deficit
$1,751 $3,440

ParkerVision, Inc.
Summary Results of Operations


Year Ended
(in thousands, except per share amounts)
December 31,

2022 2021



Licensing revenue
$925 $144
Cost of sales
(10) (5)
Gross margin
915 139

Selling, general and administrative expenses
7,773 8,088
Total operating expenses
7,773 8,088

Interest and other income
103 242
Interest expense
(324) (251)
Change in fair value of contingent payment obligations
(2,734) (4,372)
Total interest and other
(2,955) (4,381)

Net loss
$(9,813) $(12,330)

Basic and diluted net loss per common share
$(0.13) $(0.17)

Weighted average shares outstanding
78,395 71,299

ParkerVision, Inc.
Summary of Cash Flows


Year Ended
(in thousands)
December 31,

2022 2021
Net cash used in operating activities
$(2,959) $(7,702)
Net cash used in investing activities
(4) (3)
Net cash provided by financing activities
2,042 7,108

Net decrease in cash & cash equivalents
(921) (597)

Cash & cash equivalents - beginning of year
1,030 1,627

Cash & cash equivalents - end of year
$109 $1,030

SOURCE: ParkerVision, Inc.



View source version on accesswire.com:
https://www.accesswire.com/746131/ParkerVision-Reports-2022-Results

FAQ

What were the financial results for ParkerVision (PRKR) in 2022?

ParkerVision reported a net loss of $9.8 million for 2022, an improvement from $12.3 million in 2021.

How much did ParkerVision receive from patent settlements?

ParkerVision received $25 million in gross proceeds from patent settlements in early 2023.

What is ParkerVision's strategy for 2023?

The company aims for profitability in 2023 by leveraging ongoing patent enforcement actions.

What is the status of the patent infringement cases against Qualcomm?

ParkerVision's appeal against Qualcomm is expected to be heard in mid-2023.

How much cash did ParkerVision use for operations in 2022?

The company used approximately $3 million for operations in 2022, down from $7.7 million in 2021.

PARKERVISION INC

OTC:PRKR

PRKR Rankings

PRKR Latest News

PRKR Stock Data

84.95M
90.53M
10.48%
5.99%
10.51%
Semiconductors
Technology
Link
United States of America
Jacksonville